Target
Galectin-9
Ligand
BDBM50509531
Substrate
n/a
Meas. Tech.
ChEMBL_1838663 (CHEMBL4338796)
Kd
5800±n/a nM
Citation
 Mahanti, MPal, KBSundin, APLeffler, HNilsson, UJ Epimers Switch Galectin-9 Domain Selectivity: 3 ACS Med Chem Lett 11:34-39 (2020) [PubMed]  Article 
Target
Name:
Galectin-9
Synonyms:
LEG9_HUMAN | LGALS9
Type:
PROTEIN
Mol. Mass.:
39532.33
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1454626
Residue:
355
Sequence:
MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQNPRTVPVQPAFSTVPFSQPVCFPPRPRGRRQKPPGVWPANPAPITQTVIHTVQSAPGQMFSTPAIPPMMYPHPAYPMPFITTILGGLYPSKSILLSGTVLPSAQRFHINLCSGNHIAFHLNPRFDENAVVRNTQIDNSWGSEERSLPRKMPFVRGQSFSVWILCEAHCLKVAVDGQHLFEYYHRLRNLPTINRLEVGGDIQLTHVQT
  
Inhibitor
Name:
BDBM50509531
Synonyms:
CHEMBL4446731
Type:
Small organic molecule
Emp. Form.:
C20H23Cl2NO4S
Mol. Mass.:
444.372
SMILES:
Cc1ccc(N[C@H]2[C@@H](O)[C@@H](CO)O[C@H](Sc3ccc(Cl)c(Cl)c3)[C@@H]2O)cc1C |r|
Structure:
Search PDB for entries with ligand similarity: